V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10432346 | 10053006 | 1.55 | 0 | Disease modification (D) | 2018-07-14 | 2018-08-26 | IBRUTINIB | 02 | null | IBRUTINIB | 101628029 |
| 10432483 | 10053007 | 0 | 89.3 | Palliative (P) | 2015-07-02 | 2016-10-14 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | RITUXIMAB | 101149319 |
| 10432526 | 10053008 | 0 | 56.5 | null | 2022-05-21 | 2022-05-21 | Rituximab (SUBCUTANEOUS Maintenance) | N | null | RITUXIMAB | 100042147 |
| 10432552 | 10053011 | 1.75 | 81.2 | null | 2018-06-05 | 2021-10-27 | IBRUTINIB | 02 | null | IBRUTINIB | 100099180 |
| 10432562 | 10053012 | 1.69 | 55.2 | null | 2014-12-08 | 2014-12-22 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 101516864 |
| 10432568 | 10053013 | 1.68 | 58.4 | null | 2015-04-01 | 2017-07-24 | Rituximab (INTRAVENOUS Maintenance) | 02 | null | RITUXIMAB | 100596451 |
| 10432601 | 10053016 | 1.73 | 76.2 | null | 2016-09-15 | 2019-01-09 | IBRUTINIB | 02 | null | IBRUTINIB | 101620802 |
| 10432637 | 10053018 | 1.71 | 62 | null | 2020-03-28 | 2020-05-03 | IBRUTINIB | 02 | null | IBRUTINIB | 100059867 |
| 10432674 | 10053019 | 1.69 | 47.5 | Curative (C) | 2017-02-02 | 2017-09-21 | null | 02 | N | IBRUTINIB | 100944874 |
| 10432752 | 10053024 | 1.82 | 64 | null | 2015-07-15 | 2015-07-22 | Rituximab | 02 | null | RITUXIMAB | 101036521 |
| 10432910 | 10053032 | 1.54 | 81.5 | null | 2018-10-25 | 2018-11-20 | Rituximab (Maintenance) | 02 | null | RITUXIMAB | 100899360 |
| 10432971 | 10053035 | 1.66 | 71.8 | null | 2021-07-26 | 2021-08-01 | Rituximab | 02 | null | RITUXIMAB | 101457358 |
| 10432994 | 10053037 | 1.72 | null | null | 2016-09-06 | 2016-09-06 | IBRUTINIB | 02 | null | IBRUTINIB | 101659263 |
| 10433052 | 10053038 | 1.68 | 76 | null | 2019-08-31 | 2019-09-02 | IBRUTINIB | 02 | null | IBRUTINIB | 101846424 |
| 10433186 | 10053044 | 0 | 74 | 03 | 2021-03-04 | 2021-04-04 | null | 02 | N | IBRUTINIB | 101746077 |
| 10433234 | 10053047 | 1.57 | 91.5 | 03 | 2017-03-11 | 2017-03-11 | Rituximab | 02 | N | RITUXIMAB | 100069943 |
| 10433238 | 10053048 | 1.82 | 71.8 | null | 2021-08-25 | 2021-08-25 | Rituximab | 02 | null | RITUXIMAB | 100942388 |
| 10433265 | 10053050 | null | 68.2 | Palliative (P) | 2018-05-08 | 2020-03-23 | null | 02 | N | RITUXIMAB | 100139757 |
| 10433271 | 10053052 | 1.8 | 78.6 | null | 2017-11-11 | 2017-12-02 | IBRUTINIB | 02 | null | IBRUTINIB | 101546638 |
| 10433283 | 10053053 | 1.75 | 57 | null | 2013-11-10 | 2016-07-06 | IBRUTINIB | 02 | null | IBRUTINIB | 101002256 |
| 10433340 | 10053057 | 1.76 | 101.7 | null | 2017-09-23 | 2019-12-04 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101681739 |
| 10433477 | 10053060 | null | null | Adjuvant (A) | 2017-10-25 | 2017-10-26 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100250099 |
| 10433521 | 10053062 | 1.6 | 71.7 | Palliative (P) | 2019-02-14 | 2019-03-02 | null | 02 | N | DOCETAXEL | 100954070 |
| 10433527 | 10053063 | 1.8 | 92.3 | Palliative (P) | 2022-01-18 | 2022-02-09 | Docetaxel | 02 | N | DOCETAXEL | 100731679 |
| 10433573 | 10053065 | 1.73 | 90.7 | Palliative (P) | 2019-12-14 | 2019-12-28 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100666330 |
| 10433642 | 10053067 | 1.7 | 118 | Palliative (P) | 2012-11-09 | 2014-01-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100244993 |
| 10433690 | 10053068 | 1.73 | 0 | 03 | 2019-06-19 | 2019-07-04 | Enzalutamide | null | null | ENZALUTAMIDE | 101533706 |
| 10433705 | 10053069 | 1.67 | 85 | null | null | 2017-04-11 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101415202 |
| 10433749 | 10053070 | 1.75 | 96.4 | null | 2017-05-01 | 2017-08-03 | LENALIDOMIDE + dexamethasone | 02 | null | DOCETAXEL | 100570139 |
| 10433757 | 10053071 | 1.8 | 81 | null | 2018-01-13 | 2019-07-18 | LENALIDOMIDE | 02 | N | LENALIDOMIDE | 101626879 |
| 10433819 | 10053073 | 1.67 | 65.3 | null | 2017-09-12 | 2017-09-14 | Docetaxel | 02 | null | DOCETAXEL | 101382804 |
| 10433889 | 10053075 | null | null | Adjuvant (A) | 2012-03-16 | 2012-03-17 | Enzalutamide | 02 | Y | ENZALUTAMIDE | 100120423 |
| 10433900 | 10053076 | 0 | 0 | null | 2016-11-30 | 2016-12-05 | Enzalutamide | 02 | null | ENZALUTAMIDE | 100173101 |
| 10433912 | 10053077 | 0 | null | null | 2016-05-22 | 2016-08-13 | LENALIDOMIDE | 02 | null | LENALIDOMIDE | 100852199 |
| 10433988 | 10053081 | 1.62 | 80.8 | null | 2014-04-05 | 2014-04-23 | null | 02 | null | ENZALUTAMIDE | 100516920 |
| 10434030 | 10053084 | 1.62 | 62 | null | 2014-04-14 | 2018-06-21 | Lenalidomide 10mg (Cycle 1 to 25) | N | null | LENALIDOMIDE | 101074993 |
| 10434059 | 10053085 | 0 | 92.3 | null | 2017-07-28 | 2017-09-11 | Docetaxel | 02 | null | DOCETAXEL | 100656783 |
| 10434117 | 10053088 | 1.67 | null | null | null | 2017-09-17 | LENALIDOMIDE | 02 | null | LENALIDOMIDE | 101101215 |
| 10434149 | 10053089 | 1.77 | 50.2 | null | 2019-03-19 | 2019-03-29 | LENALIDOMIDE | 02 | null | PEMBROLIZUMAB | 100203036 |
| 10434185 | 10053090 | 0 | 88 | null | 2022-01-29 | 2022-03-01 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100064687 |
| 10434187 | 10053091 | 1.84 | 95 | null | 2016-08-22 | 2016-12-22 | Docetaxel | 02 | null | DOCETAXEL | 101300225 |
| 10434208 | 10053093 | null | 0 | null | 2020-12-21 | 2021-01-18 | LENALIDOMIDE + dexamethasone | 02 | null | LENALIDOMIDE | 100486257 |
| 10434232 | 10053097 | 1.69 | 100 | null | 2020-09-11 | 2020-09-12 | Enzalutamide | 02 | null | ENZALUTAMIDE | 101241361 |
| 10434238 | 10053098 | null | null | null | 2018-02-16 | 2018-02-16 | Enzalutamide | 02 | null | ENZALUTAMIDE | 101613749 |
| 10434249 | 10053099 | 1.74 | 65 | 03 | 2016-01-30 | 2016-02-04 | Docetaxel | 02 | Y | DOCETAXEL | 101120151 |
| 10434302 | 10053102 | 1.77 | 57 | null | 2018-05-27 | 2018-06-10 | null | 02 | null | PEMBROLIZUMAB | 100855088 |
| 10434308 | 10053103 | 1.69 | 79 | Palliative (P) | 2015-12-28 | 2016-01-16 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101640079 |
| 10434327 | 10053105 | 1.59 | 58.2 | null | 2022-05-12 | 2022-05-27 | LENALIDOMIDE + dexamethasone. | null | null | LENALIDOMIDE | 101113225 |
| 10434353 | 10053107 | 1.68 | null | null | 2019-04-17 | 2019-04-24 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101800390 |
| 10434363 | 10053108 | 0 | null | Palliative (P) | 2017-08-22 | 2017-09-11 | LENALIDOMIDE | null | N | LENALIDOMIDE | 101069419 |